Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine in Tardive Dyskinesia
NCT07105111Phase 4Recruiting
- Sponsor
- Neurocrine Biosciences
- Start
- Aug 2025
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started Aug 2025; status: recruiting.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT07105111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07105111.